| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6191660 | European Journal of Surgical Oncology (EJSO) | 2015 | 41 Pages |
Abstract
The addition of HIPEC to CRS and chemotherapy improves overall survival rates for both primary and recurrent EOC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Y.R. Huo, A. Richards, W. Liauw, D.L. Morris,